Ritedose Pharmaceuticals Solutions

Ritedose Pharmaceuticals presents the Ipratropium Bromide/Albuterol Sulfate Inhalation Solution, designed for those suffering from respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. This carefully formulated solution combines Ipratropium Bromide and Albuterol Sulfate to offer relief by relaxing and opening air passages in the lungs, making breathing more manageable.

Each dose contains 0.5mg of Ipratropium Bromide and 3mg of Albuterol Sulfate, packed in a convenient 3mL vial which ensures easy and precise administration. Packaged in two cartons with 30 vials each, this product is ideal for medical facilities and home use, providing a perfect balance of efficacy and convenience. Essential for preserving quality life in patients with challenging respiratory conditions.

• Convenient small dosage form: 3mL units for easy administration and transport.
• Combines two bronchodilators with fast-acting and long-lasting properties for optimal breathing relief.

• Ipratropium Bromide/Albuterol Sulfate Inhalation Solution is used for the treatment and management of symptoms in patients with chronic obstructive pulmonary disease (COPD) and asthma. It helps to relax muscles in the airways to improve breathing.

1. What are the primary uses of this inhalation solution?
It is mainly used to relieve symptoms of COPD and asthma by relaxing the muscles in your airways.

2. How should the Ipratropium Bromide/Albuterol Sulfate solution be stored?
Store at room temperature, away from light and moisture. Keep it out of the reach of children.